These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32761891)

  • 1. Age as a factor in treatment of aspirin-exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization.
    Locke TB; Sweis AM; Gleeson PK; Lin TC; Civantos AM; Parhar HS; Corr AM; Kumar A; Salmon MK; Kohanski MA; Palmer JN; Bosso JV; Adappa ND
    Int Forum Allergy Rhinol; 2020 Oct; 10(10):1180-1181. PubMed ID: 32761891
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
    Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
    Buchheit KM; Hacker J; Maurer R; McGill A; Ryan T; Bensko JC; Laidlaw TM
    Clin Exp Allergy; 2023 Sep; 53(9):974-977. PubMed ID: 37246613
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease.
    Cahill KN
    J Allergy Clin Immunol; 2021 Aug; 148(2):344-347. PubMed ID: 34144108
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin-exacerbated respiratory disease: not always "adult-onset".
    Tuttle KL; Schneider TR; Henrickson SE; Morris D; Abonia JP; Spergel JM; Laidlaw TM
    J Allergy Clin Immunol Pract; 2016; 4(4):756-8. PubMed ID: 27393784
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease.
    Pitlick MM; Pongdee T
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2187-2190.e1. PubMed ID: 35598867
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
    Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches.
    Schlosser RJ
    Int Forum Allergy Rhinol; 2020 Sep; 10(9):1035-1036. PubMed ID: 32634286
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin desensitization for aspirin-exacerbated respiratory disease in the era of biologics: Clinical perspective.
    Bosso JV
    Int Forum Allergy Rhinol; 2021 Apr; 11(4):822-823. PubMed ID: 33070455
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin-Exacerbated Respiratory Disease.
    White AA; Stevenson DD
    N Engl J Med; 2018 Sep; 379(11):1060-1070. PubMed ID: 30207919
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
    Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.
    Cahill KN; Cui J; Kothari P; Murphy K; Raby BA; Singer J; Israel E; Boyce JA; Laidlaw TM
    Am J Respir Crit Care Med; 2019 Sep; 200(6):704-711. PubMed ID: 30978291
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease.
    White AA; Bosso JV; Stevenson DD
    Allergy Asthma Proc; 2013; 34(4):378-382. PubMed ID: 23883603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease.
    Adappa ND; Ranasinghe VJ; Trope M; Brooks SG; Glicksman JT; Parasher AK; Palmer JN; Bosso JV
    Int Forum Allergy Rhinol; 2018 Jan; 8(1):49-53. PubMed ID: 29105347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
    Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
    Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin desensitization in aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD
    Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis Exploring Sinopulmonary Outcomes of Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Chaaban MR; Moffatt D; Wright AE; Cowthran JA; Hsu ES; Kuo YF
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):11-18. PubMed ID: 32571140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin tolerance in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease following treatment with omalizumab.
    Phillips-Angles E; Barranco P; Lluch-Bernal M; Dominguez-Ortega J; López-Carrasco V; Quirce S
    J Allergy Clin Immunol Pract; 2017; 5(3):842-845. PubMed ID: 28117272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.